H&E staining of LLC tumors revealed enhanced tumor cell death (Figure 1E), while IHC and Western blot confirmed PD-L1 downregulation (Figure 1F) and reduced CRTC1 protein levels (Figure 1G) in treated tumors, respectively. The gene discussed is CRTC1; the disease is neoplasm.